levofolic 50 mg/ml raztopina za injiciranje/infundiranje
medac gmbh - levofolinska kislina - raztopina za injiciranje/infundiranje - levofolinska kislina 50 mg / 1 ml - zdravila za zaščito organizma pri zdravljenju neoplazem
levofolic 50 mg/ml raztopina za injiciranje/infundiranje
medac gmbh - levofolinska kislina - raztopina za injiciranje/infundiranje - levofolinska kislina 50 mg / 1 ml - zdravila za zaščito organizma pri zdravljenju neoplazem
daklinza
bristol-myers squibb pharma eeig - daklatasvir dihidroklorid - hepatitis c, kronični - antivirusi za sistemsko uporabo - zdravilo daklinza je indicirano v kombinaciji z drugimi zdravili za zdravljenje okužbe s kroničnim hepatitisom c (hcv) pri odraslih (glejte poglavja 4. 2, 4. 4 in 5. za hcv genotip določene dejavnosti, glej točki 4. 4 in 5.
monkasta 10 mg filmsko obložene tablete
krka, d.d., novo mesto - montelukast - filmsko obložena tableta - montelukast 10 mg / 1 tableta - montelukast
monkasta 4 mg žvečljive tablete
krka, d.d., novo mesto - montelukast - žvečljiva tableta - montelukast 4 mg / 1 tableta - montelukast
edistride
astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - zdravila, ki se uporabljajo pri diabetesu - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. poleg drugimi zdravili za zdravljenje diabetesa tipa 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
forxiga
astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - zdravila, ki se uporabljajo pri diabetesu - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. poleg drugimi zdravili za zdravljenje diabetesa tipa 2. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 in 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.
mofenstra 4 mg zrnca
lek d.d. - montelukast - zrnca - montelukast 4 mg / 1 vrečica - montelukast
sufentanil torrex 5 mikrogramov/ml raztopina za injiciranje ali koncentrat za raztopino za infundiranje
chiesi slovenija, d.o.o. - sufentanil - raztopina za injiciranje/infundiranje - sufentanil 5 µg / 1 ml - sufentanil
atazanavir accord 300 mg trde kapsule
atazanavir - kapsula, trda - atazanavir 300 mg / 1 kapsula - atazanavir